arXivDaily arXiv每日学术速递 周一至周五更新
arXiv 1609.07585cs.CL
收藏

药物名称识别的递归神经结构研究

An Investigation of Recurrent Neural Architectures for Drug Name Recognition

University of Sydney(悉尼大学);Capital Markets CRC(资本市场合作研究中心);University of Technology Sydney(悉尼科技大学)

Raghavendra Chalapathy, Ehsan Zare Borzeshi, Massimo Piccardi

摘要:

药物名称识别(DNR)是药物警戒(PV)管道中的重要步骤。DNR的目标是在非结构化的生物医学文本中找到药物名称,并将其分类到预定义的类别中。最先进的DNR方法严重依赖于手工制作的功能和难以收集和调整的特定于域的资源。出于这个原因,本文研究了当代递归神经架构的有效性-Elman和Jordan网络以及带有CRF解码的双向LSTM-直接从文本执行DNR。在权威的SemEval-2013 Task 9.1基准测试中获得的实验结果表明,双向LSTM-CRF与高度专用的手工制作的系统非常接近。

英文摘要:

Drug name recognition (DNR) is an essential step in the Pharmacovigilance (PV) pipeline. DNR aims to find drug name mentions in unstructured biomedical texts and classify them into predefined categories. State-of-the-art DNR approaches heavily rely on hand crafted features and domain specific resources which are difficult to collect and tune. For this reason, this paper investigates the effectiveness of contemporary recurrent neural architectures - the Elman and Jordan networks and the bidirectional LSTM with CRF decoding - at performing DNR straight from the text. The experimental results achieved on the authoritative SemEval-2013 Task 9.1 benchmarks show that the bidirectional LSTM-CRF ranks closely to highly-dedicated, hand-crafted systems.

机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。

↑